Showing results (81-90 of 99) with videos related to

Sort By:
Pageof 10
The Journal of Pharmacy and Pharmacology|October 3, 2024
Osteogenic effect of alogliptin in chemical-induced bone loss: a tri-modal in silico, in vitro, and in vivo analysisFaraha Ahmed, Syed Sufian Ahmad, Mohammad Mumtaz Alam, et al.
Future Medicinal Chemistry|September 21, 2023
Synthesis and HDAC1 inhibitory activity of a novel series of coumarin-based amide derivatives for treatment of cancerSharba Tasneem, M Mumtaz Alam, Suhel Parvez, et al.
Acta Poloniae Pharmaceutica|January 5, 2013
Anti-inflammatory and antimicrobial activity of 4,5-dihydropyrimidine-5-carbonitrile derivatives: their synthesis and spectral elucidationMohammad Mumtaz Alam, Mymoona Akhter, Asif Husain, et al.
Future Medicinal Chemistry|January 19, 2023
Pyrazoline scaffold: hit identification to lead synthesis and biological evaluation as antidiabetic agentsShweta Sharma, Mohd Hafizur Rehman Ansari, Kalicharan Sharma, et al.
Acta Poloniae Pharmaceutica|June 14, 2013
Microwave assisted one pot synthesis of some pyrazole derivatives as a safer anti-inflammatory and analgesic agentsMohammad Mumtaz Alam, Akranth Marella, Mymoona Akhtar, et al.
European Journal of Pharmacology|September 22, 2019
Nerolidol attenuates cyclophosphamide-induced cardiac inflammation, apoptosis and fibrosis in Swiss Albino miceAshif Iqubal, Sumit Sharma, Mohd Asif Ansari, et al.
Bioorganic Chemistry|May 31, 2022
Synthesis, biological evaluation and docking studies of methylene bearing cyanopyrimidine derivatives possessing a hydrazone moiety as potent Lysine specific demethylase-1 (LSD1) inhibitors: A promising anticancer agentsSharba Tasneem, Khursheed A Sheikh, Md Naematullah, et al.
European Journal of Medicinal Chemistry|August 14, 2025
Tranylcypromine-derived LSD1 inhibitors: Synthetic strategies, structure-activity relationships, and anticancer potentialKhursheed Ahmad Sheikh, Siddiqui Muzammil, Elaf Raneem, et al.
Archiv Der Pharmazie|October 5, 2020
Design and synthesis of pyrazole-pyrazoline hybrids as cancer-associated selective COX-2 inhibitorsWasim Akhtar, Akranth Marella, Mohammad Mumtaz Alam, et al.
European Journal of Medicinal Chemistry|February 19, 2019
Revealing quinquennial anticancer journey of morpholine: A SAR based reviewFatima Arshad, Mohemmed Faraz Khan, Wasim Akhtar, et al.
Pageof 10